Search Results 131-140 of 11723 for ���������������������������:za33���24������ ������������������������ ������

  1. Gastroenterology and Hepatology - Clinical trials

    ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Data Collection of PillCamTM SB3 Capsule Endoscopy and Device-Assisted Enteroscopy ...

  2. ... 24,24, 300000000,HC 2D6 SEQUENCING,548,548, 300000002,HC 5-HTT GENE ANALYSIS,338,338, 300000004,HC ABL1 KD VARIANTS,705,850, 300000005,HC ACADS KNOWN ...

  3. Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment - Mayo Clinic

    ... 24 hours[hrs]); OR - IgA, IgM, IgD, or IgE multiple myeloma (serum M-protein level >= 0.2 g/dL or urine M-protein level >= 200 mg/24 hrs); OR - Light chain ...

  4. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy Duration - Mayo Clinic

    creatinine clearance (CrCl) ≥ 30 mL/min., as measured by a 24-hour urine collection, or estimated by the Cockcroft and Gault formula; or; serum creatinine ...

  5. Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Study ACT16970 consists of 2 parts (A and B) as follows: Part A is a 24 week, double blind, placebo controlled part, preceded by a screening period of up to ...

  6. Medical Research & Education - Mayo Clinic News Network

    24 · 25 · 26 · 27 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...

  7. Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Systemic Sclerosis - Mayo Clinic

    Serum creatinine must be stable (with no increases ≥ 20%) for a minimum of 24 weeks post-renal crisis at the time of the screening visit. Cardiac ...

  8. A Trial To Find Out If REGN5678 Is Safe And How Well It Works Alone Or In Combination With Cemiplimab For Adult Participants With Metastatic Castration-Resistant Prostate Cancer And Other Tumors - Mayo Clinic

    Rochester, Minnesota: 24-008602; Jacksonville, Florida: 24-008602; Scottsdale/Phoenix, Arizona: 24-008602. NCT ID: NCT03972657. Sponsor Protocol Number: R5678 ...

  9. Belzutifan with Von Hippel-Lindau (VHL) - Mayo Clinic

    Rochester, Minnesota: 24-007537; Scottsdale/Phoenix, Arizona: 24-007537. Sponsor Protocol Number: 6482-026. About this study. The purpose of this study is to ...

  10. Breast cancer - Doctors and departments - Mayo Clinic

    Suspicious area Bi-rad 2 or 3: Do I advocate for a biopsy or wait? 50 Replies Sat, May 24, 2025. See more discussions. Related. Breast cancer chemoprevention ...